Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet

Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name "Covihalt" for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in...